Neurology-focused biopharma (epilepsy, depression)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 75 | Added +813% | 1,190,201 | $44,263,575 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -95% | 24,783 | $921,680 | 0.0% |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-10-01 | MORTIMER IAN (cluster of 2) | director+officer | 30,000 | $1,121,400 | Form 4 |
| 2026-10-01 | Kelly Thomas Patrick (cluster of 2) | officer | 15,000 | $559,740 | Form 4 |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.